Company Profiles

driven by the PitchBook Platform

SphynKx Therapeutics

Description

Operator of a biotechnology company focused on the development of therapies for the treatment of fibrosis. The company develops small molecule therapeutics that target the sphingosine 1-phosphate (S1P) pathway for treatment of diseases, such as fibrosis and cancer.

2010

Founded

PRIVATE

Status

11-50

Employees

Grant

Latest Deal Type

$50k

Total Amount Raised

3

Investors

Description

Operator of a biotechnology company focused on the development of therapies for the treatment of fibrosis. The company develops small molecule therapeutics that target the sphingosine 1-phosphate (S1P) pathway for treatment of diseases, such as fibrosis and cancer.

Website:

www.sphynkx.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Other Pharmaceuticals and Biotechnology
Biotechnology

Primary Office

Charlottesville, VA United States
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore SphynKx Therapeutics's full profile, request a free trial.

SphynKx Therapeutics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

SphynKx Therapeutics Investors (3)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Center for Innovative Technology Gap FundsVenture CapitalMinority000 0000000 0000
Commonwealth Research Commercialization FundOther000 0000000 0000
National Institutes of HealthGovernment000 0000000 0000
Center for Innovative Technology Gap Funds Venture Capital
Commonwealth Research Commercialization Fund Other
National Institutes of Health Government

SphynKx Therapeutics Executive Team (4)

NameTitleBoard
Seat
Contact
Info
Andrew BoltPresident, Chief Executive Officer & Co-Founder
Kevin Lynch Ph.DCo-Founder & Chief Scientific Officer
Timothy Macdonald Ph.DVice President, Drug Discovery & Co-Founder
Webster SantosVice President, Medicinal Chemistry & Co-Founder
Andrew Bolt President, Chief Executive Officer & Co-Founder
Kevin Lynch Ph.D Co-Founder & Chief Scientific Officer
Timothy Macdonald Ph.D Vice President, Drug Discovery & Co-Founder
Webster Santos Vice President, Medicinal Chemistry & Co-Founder
Request full access to PitchBook